| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2015 | Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project | Kim, Y. H.; Tavallaee, M.; Sundram, U.; Salva, K. A.; Wood, G. S.; Li, S. F.; Rozati, S.; Nagpal, S.; Krathen, M.; Reddy, S.; Hoppe, R. T.; Nguyen-Lin, A.; Wen-Kai Weng ; Armstrong, R.; Pulitzer, M.; Advani, R. H.; Horwitz, S. M. | Journal of Clinical Oncology |
